Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24
DOI:
https://doi.org/10.2340/00015555-3905Keywords:
hidradenitis suppurativa, quality of life, patient-reported outcome measure, psychometrics, validationAbstract
To date, there are no disease-specific instruments in Spanish to assess quality of life of patients with hidradenitis suppurativa. A multicentre study was previously carried out in Spain between 2016 and 2017 to develop the Hidradenitis Suppurativa Quality of Life -24 (HSQoL-24), a disease-specific questionnaire to assess quality of life in patients with hidradenitis suppurativa. The objectives of this study are to revalidate the HSQoL-24 in Spanish with a larger sample of patients, and to present the English version. In this multicentre study in Spain, patients with hidradenitis suppurativa completed the HSQoL-24, the Dermatology Life Quality Index and the Skindex-29. The Hurley staging system was used to assess the severity of the disease. Validation of the questionnaire was carried out in 130 patients, of whom 75 (57.7%) were women. This study demonstrates adequate values of reliability and validity of the HSQoL-24, confirming the previous test re-test validation and making this questionnaire one of wide clinical validity in terms of results perceived by patients.
Downloads
References
Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec G, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984–991.
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045–1058.
Von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809–813.
Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90: 264–268.
Thorlacius L, Cohen AD, Gislason GH, Jemec G, Egeberg A. Increased suicide risk in patients with hidradenitis suppurativa. J Invest Dermatol 2018; 138: 52–57.
Martorell A, Garcia-Martínez FJ, Jimenez-Gallo D, Pascual JC, Pereyra-Rodríguez J, Salgado L, et al. An update on hidradenitis suppurativa (Part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr 2015; 106: 703–715.
Martorell A, Garcia FJ, Jimenez-Gallo D, Pascual JC, Pereyra-Rodríguez J, Salgado L, et al. et al. Update on hidradenitis suppurative (Part II): treatment. Actas Dermosifiliogr 2015; 106: 716–724.
Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec G, Svensson A, Manolache L, et al. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol 2019; 33: 1633–1643.
Mac Mahon J, Kirthi S, Byrne N, O’Gradyet N, Tobin AM. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas 2020; 11: 21–26.
Thorlacius L, Esmann S, Miller I, Miller I, Vinding G, Jemec G. Development of HiSQOL: a hidradenitis suppurativa-specific quality of life instrument. Ski Appendage Disord 2019; 5: 221–229.
McLellan C, Sisic M, Oon HH, Tan J. Preliminary validation of the HS-QoL: a quality-of-life measure for hidradenitis suppurativa. J Cutan Med Surg 2018; 22: 142–146.
Kirby JS, Thorlacius L, Villumsen B, Ingram JR, Garg A, Christensen KB, et al. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. Br J Dermatol 2020; 183: 340–348.
Sisic M, Kirby JS, Boyal S, Plant L, Mc Lellan Ch, Tan J. Development of a quality-of-life measure for hidradenitis suppurativa. J Cutan Med Surg 2017; 21: 152–155.
Marron SE, Gomez-Barrera M, Tomas-Aragones L, Díaz Díaz RM, Vilarrasa Rull E, Madrid Álvarez MB, Puig L. Development and preliminary validation of the HSQoL-24 tool to assess quality of life in patients with hidradenitis suppurativa. Actas Dermosifiliogr 2019; 110: 554–560.
Finlay AY, Khan GK. Dermatology life quality index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
Jones-Caballero M, Peñas PF, García-Díez A, Chren MM, Badía X. The Spanish version of Skindex-29. An instrument for measuring quality of life in patients with cutaneous diseases. Med Clin (Barc) 2002; 118: 5–9.
Wild D, Grove, Martin M, McElroy S, Verjee-Lorenz A, Erikson P. Principles of good practice for the translation and cultural adaptation process for patients-reported outcomes (PRO) measures: report of the of the ISPOR Task Force for Translation and Cross-Cultural Adaptation. Value Health 2005; 8: 94–104.
Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 2005; 28: 212–232.
Oosterhaven JAF, Schuttelaar MLA, Apfelbacher C, Diepgen TL, Ofenloch RF. Guideline for translation and national validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ). Contact Dermatitis 2017; 77: 106–115.
Kouris A, Platsidaki E, Christodoulou C, Efstathiou V, Dessinioti C, Tzanetakou V, et al. Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology 2016; 232: 687–691.
Pavon Blanco A, Turner MA, Petrof G, Weinman J. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa. Br J Dermatol 2018; 180: 338–345.
Kjaersgaard Andersen R, Theut Riis P, Jemec GBE. Factors predicting the self-evaluated health of hidradenitis suppurativa patients recruited from an outpatient clinic. J Eur Acad Dermatol Venereol 2018; 32: 313–317.
Dauden E, Herrera E, Puig L, Toribio J, Caloto MT, Nocea G, et al. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health Qual Life Outcomes 2012; 10: 56.
Lam C, Liu SW, Townsend HB, Femia AN, Qureshi AA, Vleugels RA. Development and pilot testing of the cutaneous lupus screening tool. JAMA Dermatol 2016; 152: 60–66.
Esmann S, Dufour DN, Jemec GB. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions. Br J Dermatol 2010; 163: 102–116.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
